Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefani Spranger

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Annals of the New York Academy of Sciences|November 13, 2020
Frontiers in cancer immunotherapy-a symposium reportJennifer Cable, Benjamin Greenbaum, Dana Pe'er, et al.
Journal for Immunotherapy of Cancer|December 1, 2019
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy)Paolo A Ascierto, Carlo Bifulco, Luigi Buonaguro, et al.
Immunity|July 1, 2025
Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancerDig B Mahat, Heena Kumra, Sarah A Castro, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
The CD8 immgenT framework as a universal reference of mouse CD8αβ T cell differentiation statesGiovanni Galletti, Anna-Maria Globig, Olga Barreiro, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
Mutant p53 Exploits Enhancers to Elevate Immunosuppressive Chemokine Expression and Impair Immune Checkpoint Inhibitors in Pancreatic CancerDig B Mahat, Heena Kumra, Sarah A Castro, et al.
Nature|June 15, 2022
Deciphering the immunopeptidome in vivo reveals new tumour antigensAlex M Jaeger, Lauren E Stopfer, Ryuhjin Ahn, et al.
Med (New York, N.Y.)|November 11, 2023
Transforming ovarian cancer care by targeting minimal residual diseaseAmir A Jazaeri, Rachel Grisham, Anne Knisely, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Buoyant mass reveals distinct T cell states predictive of checkpoint responseJiaquan Yu, Ye Zhang, Sarah M Duquette, et al.
Nature Cancer|September 22, 2022
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypesSatyaki Sengupta, Sanjukta Das, Angela C Crespo, et al.
Nature Biotechnology|May 11, 2023
A prime editor mouse to model a broad spectrum of somatic mutations in vivoZackery A Ely, Nicolas Mathey-Andrews, Santiago Naranjo, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Annals of the New York Academy of Sciences|November 13, 2020
Frontiers in cancer immunotherapy-a symposium reportJennifer Cable, Benjamin Greenbaum, Dana Pe'er, et al.
Journal for Immunotherapy of Cancer|December 1, 2019
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy)Paolo A Ascierto, Carlo Bifulco, Luigi Buonaguro, et al.
Immunity|July 1, 2025
Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancerDig B Mahat, Heena Kumra, Sarah A Castro, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
The CD8 immgenT framework as a universal reference of mouse CD8αβ T cell differentiation statesGiovanni Galletti, Anna-Maria Globig, Olga Barreiro, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
Mutant p53 Exploits Enhancers to Elevate Immunosuppressive Chemokine Expression and Impair Immune Checkpoint Inhibitors in Pancreatic CancerDig B Mahat, Heena Kumra, Sarah A Castro, et al.
Nature|June 15, 2022
Deciphering the immunopeptidome in vivo reveals new tumour antigensAlex M Jaeger, Lauren E Stopfer, Ryuhjin Ahn, et al.
Med (New York, N.Y.)|November 11, 2023
Transforming ovarian cancer care by targeting minimal residual diseaseAmir A Jazaeri, Rachel Grisham, Anne Knisely, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Buoyant mass reveals distinct T cell states predictive of checkpoint responseJiaquan Yu, Ye Zhang, Sarah M Duquette, et al.
Nature Cancer|September 22, 2022
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypesSatyaki Sengupta, Sanjukta Das, Angela C Crespo, et al.
Nature Biotechnology|May 11, 2023
A prime editor mouse to model a broad spectrum of somatic mutations in vivoZackery A Ely, Nicolas Mathey-Andrews, Santiago Naranjo, et al.
Pageof 9